banner
Inquiry

Liposomes

Cat. No. Product Name Inquiry
X26-05-ZQ1920 Neogambogic acid mPEGylated liposomes
X26-05-ZQ1921 Cyclopamine-phospholipid copolymer modified functionalized epirubicin liposomes
X26-05-ZQ1922 Cell-penetrating peptide TAT and PEG co-modified doxorubicin-loaded liposomes
X26-05-ZQ1923 Cell-penetrating peptide TAT and cleavable PEG co-modified paclitaxel-loaded liposomes
X26-05-ZQ1924 PEG-modified β-sitosterol based novel Gynostemma pentaphyllum total saponins long-circulating liposomes
X26-05-ZQ1925 pH-Sensitive resveratrol long-circulating liposomes
X26-05-ZQ1926 PEG-modified allicin long-circulating liposomes (PEG-DATS-LCL)
X26-05-ZQ1927 Polyethylene glycol-distearoylphosphatidylethanolamine modified doxorubicin stealth liposomes
X26-05-ZQ1928 Breviscapine long-circulating nanoliposomes
X26-05-ZQ1929 Cell-penetrating peptide R8 and pH-sensitive cleavable PEG co-modified liposomes
X26-05-ZQ1930 Mitoxantrone folate-targeted liposomes
X26-05-ZQ1931 Liposome-mimetic composite micelles
X26-05-ZQ1932 Amphiphilic liposome-mimetic micelles
X26-05-ZQ1933 RGD-mediated docetaxel pH-sensitive liposomes
X26-05-ZQ1934 Paeonol VEGF antibody-modified liposomes
X26-05-ZQ1935 Galactosylated liposomes
X26-05-ZQ1936 Biomimetic quantum dot liposome nanoprobes (PEG-LP-QDs)
X26-05-ZQ1937 Cholesterol derivative liposomes
X26-05-ZQ1938 Radix Salviae Miltiorrhizae total phenolic acid long-circulating liposomes
X26-05-ZQ1939 Cell-penetrating peptide-modified paclitaxel and tamoxifen liposomes
X26-05-ZQ1940 Thiol-functionalized surface liposomes (HS-Gd-SLs)
X26-05-ZQ1941 Resveratrol long-circulating liposomes (LP-RSV)
X26-05-ZQ1942 Phosphatidylethanolamine-polyethylene glycol-folate modified nano-paclitaxel liposomes
X26-05-ZQ1943 Endoglin antibody-conjugated liposomes
X26-05-ZQ1944 Polyethylene glycol POPA phospholipid derivative-constructed acid-sensitive liposomes
X26-05-ZQ1945 Folate receptor-targeted cationic liposomes
X26-05-ZQ1946 Epirubicin hydrochloride liposomes
X26-05-ZQ1947 PDP-PEG-HEPE containing gadolinium sterically stabilized liposomes (PDP-Gd-SLs)
X26-05-ZQ1948 Dequalinium-polyethylene glycol-distearoylphosphatidylethanolamine modified resveratrol liposomes
X26-05-ZQ1949 EGFR receptor-mediated lung tumor-targeted siRNA lipopolyamine-modified liposomes
X26-05-ZQ1950 Iridium(III) complex long-circulating liposomes
X26-05-ZQ1951 RGD peptide and cleavable PEG co-modified liposomes
X26-05-ZQ1952 Paclitaxel palmitate (PTX-PA) long-circulating liposomes
X26-05-ZQ1953 Oxymatrine sterically stabilized liposomes
X26-05-ZQ1954 Long-circulating superparamagnetic iron oxide liposomal nanoparticles
X26-05-ZQ1955 Adriamycinone B long-circulating nanoliposomes
X26-05-ZQ1956 Superoxide dismutase liposomes (SOD LPs)
X26-05-ZQ1957 Octreotide-targeted doxorubicin liposomes
X26-05-ZQ1958 BCG polysaccharide nucleic acid liposomes
X26-05-ZQ1959 Betaxolol hydrochloride (BH) cationic liposomes

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.